Antibiotic

A Major Breakthrough: Wockhardt's Zaynich Gets US FDA Nod, Offering New Hope Against Stubborn UTIs

Wockhardt Secures US FDA Approval for Zaynich, Shifts Gears from Lab Bench to Marketplace

A Game-Changer in India's Fight Against Superbugs

Unveiling a Hidden Link: Common Acne Drug Minocycline and Schizophrenia Risk

Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

The Superbug Slayer We've Been Waiting For? A Remarkable New Antibiotic Emerges

Urgent Health Alert: Abbott Warns of Dangerous Counterfeit Amoxyclav Batches Circulating in India

India's New Weapon Against Superbugs: Wockhardt's Zaynich Offers Hope in Global AMR Crisis

Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs

MicrobiotiX Secures Landmark KRW 20 Billion Series B Funding, Catalyzing Korea's First-Ever Bacteriophage Clinical Trial to Combat Superbugs